A groundbreaking achievement has been reached in the fight against malaria. Novartis announced today that its revolutionary treatment has received official approval to treat malaria in newborns and infants, signaling a major advancement in global health. This cutting-edge medicine will now be available to countries where malaria is most prevalent,